Free Trial
NASDAQ:PBM

Psyence Biomedical (PBM) Stock Price, News & Analysis

Psyence Biomedical logo
$2.36 -2.67 (-53.08%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$3.98 +1.63 (+68.86%)
As of 08/1/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Psyence Biomedical Stock (NASDAQ:PBM)

Key Stats

Today's Range
$2.36
$4.68
50-Day Range
$2.36
$11.50
52-Week Range
$2.36
$345.00
Volume
2.31 million shs
Average Volume
1.94 million shs
Market Capitalization
$1.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Psyence Biomedical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

PBM MarketRank™: 

Psyence Biomedical scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Psyence Biomedical.

  • Price to Book Value per Share Ratio

    Psyence Biomedical has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.81% of the float of Psyence Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Psyence Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Psyence Biomedical has recently decreased by 37.98%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Psyence Biomedical does not currently pay a dividend.

  • Dividend Growth

    Psyence Biomedical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.81% of the float of Psyence Biomedical has been sold short.
  • Short Interest Ratio / Days to Cover

    Psyence Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Psyence Biomedical has recently decreased by 37.98%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Psyence Biomedical has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Psyence Biomedical this week, compared to 1 article on an average week.
  • Search Interest

    2 people have searched for PBM on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Psyence Biomedical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.60% of the stock of Psyence Biomedical is held by insiders.

  • Percentage Held by Institutions

    77.44% of the stock of Psyence Biomedical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Psyence Biomedical's insider trading history.
Receive PBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psyence Biomedical and its competitors with MarketBeat's FREE daily newsletter.

PBM Stock News Headlines

He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.
See More Headlines

PBM Stock Analysis - Frequently Asked Questions

Psyence Biomedical's stock was trading at $16.8167 at the start of the year. Since then, PBM stock has decreased by 86.0% and is now trading at $2.36.

Psyence Biomedical Ltd. (NASDAQ:PBM) released its quarterly earnings data on Thursday, January, 23rd. The company reported $4.06 earnings per share (EPS) for the quarter.

Psyence Biomedical shares reverse split on the morning of Monday, May 5th 2025.A 100-797 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, May 4th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Psyence Biomedical's top institutional investors include Parallel Advisors LLC (48.25%).

Shares of PBM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
1/23/2025
Today
8/02/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PBM
Previous Symbol
NASDAQ:PBM
CIK
1985062
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
11.04
Quick Ratio
11.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.84 per share
Price / Cash Flow
2.81
Book Value
$11.83 per share
Price / Book
0.20

Miscellaneous

Outstanding Shares
570,000
Free Float
548,000
Market Cap
$1.35 million
Optionable
N/A
Beta
0.22
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:PBM) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners